NexgenRx Inc.
NXG.V
TSX
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 189.70K | -17.20K | -46.90K | -244.70K | -229.30K |
| Total Depreciation and Amortization | 933.30K | 946.30K | 961.30K | 969.10K | 983.50K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 47.50K | 51.90K | 51.20K | 53.20K | 155.70K |
| Change in Net Operating Assets | -451.30K | 169.60K | -76.20K | 172.60K | -608.10K |
| Cash from Operations | 719.40K | 1.15M | 889.50K | 950.30K | 301.80K |
| Capital Expenditure | -50.50K | -84.60K | -66.30K | -57.30K | 195.10K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -168.50K | -124.80K | -158.70K | -127.50K | -137.90K |
| Cash from Investing | -219.00K | -209.40K | -225.00K | -184.80K | 57.30K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -98.60K | -89.40K | -82.60K | -79.20K | -78.80K |
| Issuance of Common Stock | 187.50K | 187.50K | 187.50K | 62.50K | 62.50K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -639.70K | -640.10K | -667.70K | -667.60K | -384.20K |
| Other Financing Activities | 0.00 | 33.00K | -- | -- | -- |
| Cash from Financing | -573.70K | -542.60K | -589.60K | -679.70K | -396.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -73.50K | 398.50K | 74.60K | 85.50K | -37.20K |
